Aaron Gardner is Counsel in the Corporate Department of Kaye Scholer’s New York office and a member of the firm’s Life Sciences Group. Aaron represents a variety of domestic and foreign companies, including private equity funds and publicly held and private companies in various industries, particularly the life sciences. He represents clients in a wide range of corporate transactions, including mergers and acquisitions, public and private securities offerings, corporate finance, joint ventures and strategic alliances. Aaron has experience structuring and negotiating intellectual property licenses, development, commercialization and other collaboration agreements, manufacturing and supply agreements, and counseling with respect to other complex business relationships.
Recently, Aaron was seconded as in-house counsel by a pharmaceutical client of the firm. Aaron served as senior M&A counsel in the global corporate group, where he advised on transactional matters including a major strategic acquisition and the global divestiture of a portfolio of products including branded pharmaceuticals, generics, diagnostics and over-the-counter medicines. As a result of his tenure as in-house counsel for the client, Aaron has a real-world understanding of the in-house corporate legal function, and substantial experience counseling corporate executives on a variety of legal and commercial issues.
- Kaye Scholer Advises Pfizer on Deal for the Development and Commercialization of Adult and Pediatric Growth Hormone December 15, 2014
- Kaye Scholer Advises Novartis in Collaboration Agreement with QIAGEN November 11, 2014
- Kaye Scholer Represents Pfizer in Acquisition of InnoPharma July 16, 2014